Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Inhibition of chicken adipocyte differentiation by in vitro exposure to monoclonal antibodies against embryonic chicken adipocyte plasma membranes.

Wu YJ., Wright JT., Young CR., Cartwright AL.

Animal Study on Systemic / IV, published in Poult Sci (2000) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Poult Sci (2000)
Country
England
Reported sample size
—
Source database
PubMed
PMID
10875773
DOI
10.1093/ps/79.6.892

Abstract (original English)

Specific monoclonal antibodies (MAb) against adipocyte precursor antigens were developed. These MAb identified adipocyte precursors and reduced their prominence in primary stromal-vascular (SV) cultures by complement-mediated cytotoxicity or by inhibition of differentiation. Binding of antibodies to chicken adipocyte precursors was confirmed by immunofluorescence visual examination following secondary exposure to fluorescein isothiocyanate-conjugated goat antimouse IgG. Cross-reaction of MAb with muscle, kidney, liver, fibroblasts, and other cell types not containing lipid droplets was not observed in primary cultures. Adipocyte precursors were obtained from 18-d chick embryo adipose tissue by collagenase digestion to investigate complement-mediated cytotoxicity of preadipocytes. Cultures were maintained in Medium 199 with 5% fetal bovine serum (FBS) for 4 d. Subsequently, Medium 199 supplemented with 10% chicken serum initiated adipocyte differentiation. At Day 5 postinoculation, individual or combinations of MAb were administered to preadipocyte cultures; rabbit complement was added 30 min later. After 1 d of incubation, four of the six individual MAb with complement significantly (P < 0.05) reduced the number of fat cell clusters that developed by 40 to 60%. These MAb in the presence of complement also significantly (P < 0.05) reduced mean cell width and apparent cell area o

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueAnimalsAntibodies, MonoclonalAntibody SpecificityAntigensCell DifferentiationCell MembraneCells, CulturedChick Embryo

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research